SeaStar Medical Holding Corporation (ICU)

R&D Expense Growth

-17.43%

Fiscal year · Period ending:

ICU logo

ICU R&D Expense Growth

Latest reported-17.43%
ICU FY R&D Growth (YoY) (0.00% → -17.43%)
High-resolution chart · PNG

ICU r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

SeaStar Medical Holding Corporation R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-17.43%
52.436%
138.6336%
-9.5083%
-31.2795%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.